APOE and Alzheimer disease: Understanding how the apolipoprotein E (APOE) genotype, the key genetic driver of AD risk, regulates cellular responses to Aβ plaques and neurofibrillary tangles (NFTs), as well as the microenvironment around these lesions, is critical.